Hpc Logo Stacked
Presents
2024 Combo Logo FDA
Register now

A Summit Focused on Solutions for a Dynamic Industry With Evolving Regulations 

Since 2015, the Combination Products Summit has united the healthcare products industry to work for a better tomorrow. The community continues to be led by top regulatory officials and worldwide industry leaders who built the framework for the regulatory landscape of combination products.

Cp7
2023 Cp Fireside Group Side
Combination Products 2024
2023 Cp Three Attendees Hallway
Cp6
Cp4

200+ participants

14

countries

5

continents

16

sessions

60

speakers and moderators

15

FDA speakers

19

FDA participants

Combination Products 2024 convenes October 9th – 10th in Providence, RI to drive innovation and navigate the complexities specific to the world of combination products, resulting in the delivery of safe, effective, and high-quality products to the patients who need them.  

“If your work has anything to do with combination products, you should be here!”

Amaya Hodges Jonathan

Jonathan Amaya-Hodges

Director, Technical Services, Suttons Creek Inc.

2023 Cp Audience Question Table1
Cp2
Cp5

FDA Office Hours

October 8, 2024 | 10 a.m. to 2 p.m.

In a 15-minute conversation, you and your team will have the opportunity to ask your questions, discuss your challenges, and gain the perspective of the FDA’s top combination product officials.

Join us in Providence this October for Combination Products 2024

Hosted by AFDO/RAPS Healthcare Products Collaborative and co-sponsored by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services, the event features a full-day pre-conference workshop* on October 8th followed by an in-depth conference on October 9th -10th. 

(*separate registration required for the workshop)

One-on-one meetings with FDA executives during FDA Office Hours to ask questions, discuss challenges, and gain new perspectives from top officials

Interactive presentations and vital networking opportunities that explore solutions for a dynamic industry in an ever-changing regulatory landscape

Participation in sessions, informal collaboration, and networking events focused on what’s new and what’s next for combination products 

Don’t miss the chance to engage in actionable learning and implementation plans for combination products.

Why attend the 2024 Combination Products Summit?

The 2024 featured speakers will be announced soon.

Check out last year’s featured speakers

Aftin Ross

FDA

James Bertram

FDA

John Weiner

FDA

Joo Hee Kim

Ajou University

Kate Gillespie

Johnson & Johnson

Steven Oh

FDA

Sujith Kallur

BD

Thinh Nguyen

FDA

Join Us to Explore These Hot Topics (and so much more)

From the Desk of the FDA Office of Combination Products – Strategic Priorities

Aligning Device Constituent Parts With Drug CMC Review Principles

Harmonizing U.S. FDA’s QMSR to ISO 13485: Impact to Combination Products

Challenges of Complex Generic DDCP Development and Assessment

Opportunities for Platform Technologies to Streamline Combination Product Development

Regulatory and Technical Considerations for On-Body Delivery Systems (OBDS)

Building Your Combination Product – Taking the Leap from Clinical to Commercial

The EU COMBINE Project: Medical Devices and IVDs Used in Medicinal Product Studies

Innovative Combination Products for the Next Generation of Medicine

Are you a current RAC holder? 

Attend Combination Products Summit 2024 and earn 12.0 RAC recertification credits. 

2024 Summit Sponsors

Because of the generosity of our sponsors, we can continue our work to improve the healthcare products industry and patient care.

Lilly Logo
Suttons Creek
Basil Systems Logo
Patrick Flynn

Learn more about supporting Combination Products Summit 2024 through sponsorship by contacting Patrick Flynn at +1 (301) 770-2920, ext. 246, or pflynn@raps.org.

This conference IS co-sponsored by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services. The contents are those of the presenters and do not necessarily represent the official views of, nor an endorsement by, FDA/HHS or the U.S. government.

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.

Newsletter

Stay in the know about upcoming events and breaking news from the collaborative.

Subscribe

ContACT

Have questions about our events or how to get involved with one of our committees or workgroups?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative